Business description: Mauna Kea Technologies

Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools. The group's products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. Net sales break down by activity as follows:

- sale of licenses (40.7%);

- sales of accessories (37.3%): mini-probes, software, etc.;

- sales of system (11.2%);

- services (10.8%).

Net sales are distributed geographically as follows: Europe/Middle East/Africa (15.5%), the United States and Canada (42.9%) and Asia (41.6%).

Number of employees: 65

Sales by Activity: Mauna Kea Technologies

Fiscal Period: December20192020202120222023

Endomeicroscopy

8.51M 7.24M 8.54M 8.11M 11.03M
See all business segments

Geographical breakdown of sales: Mauna Kea Technologies

Fiscal Period: December20192020202120222023

USA and Canada

- - - - 4.49M

Asia

- - - - 4.36M

EMEA (Europe, Middle East, Africa)

- - - - 1.62M

EMEA & ROW

- - - 2.88M -

Asia/Pacific

- - - 402K -

United States & Canada

- - - 4.2M -

Latin America

283K - - - -

Asia (Excluding China and Japan)

162K 137K 180K - -

Japan

41K 9K - - -

China

2.36M 1.62M 1.38M - -

EMEA (Europe, Middle East, Africa) Excluding France

883K 782K 1.68M - -

United States of America

3.43M 3.59M 4.18M - -

France

268K 396K 277K - -
See all geographic segments

Managers: Mauna Kea Technologies

Director TitleAgeSince
Chief Executive Officer - 03/10/2022
Director of Finance/CFO - 12/06/2023
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 30/04/2000
See MAUNA KEA TECHNOLOGIES governance

Members of the board: Mauna Kea Technologies

Manager TitleAgeSince
Chairman - 21/10/2018
Chairman - 12/06/2014
Director/Board Member 60 14/01/2018
Director/Board Member - 22/07/2020
Director/Board Member - 31/12/2020
Composition of the Board of Directors

Shareholders: Mauna Kea Technologies

NameEquities%Valuation
OFI Invest Asset Management SA
1.100 %
711,913 1.100 % 131 433 €
212,000 0.3277 % 39 139 €
Pure Capital SA
0.0850 %
55,000 0.0850 % 10 154 €
List of MAUNA KEA TECHNOLOGIES shareholders

Company details: Mauna Kea Technologies

Mauna Kea Technologies SA

9, rue d'Enghien

75010, Paris

+33 1 48 24 03 45

http://www.maunakeatech.com
address Mauna Kea Technologies(ALMKT)

Medical Diagnostic & Testing Equipment

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-2.29%+1.55%-59.04%-76.79%11.95M
+6.38%+6.78%-27.39%-60.27%14.26B
-4.71%-3.56%-41.26%-71.18%2.73B
+0.80%+2.89%-17.42% - 1.47B
+0.57%-0.33%-10.92%+228.39%1.41B
+0.98%+3.25%+35.97%-34.70%1.2B
+0.37%-0.06%-25.42%-60.87%888M
+2.10%-6.29%-28.04%+31.42%849M
-0.80%+0.37%+12.56%-51.23%773M
+2.02%-4.15%-21.08%-44.24%629M
Average +0.51%-0.32%-18.20%-15.50% 2.42B
Weighted average by Cap. +3.27%-1.48%-22.77%-38.19%
See all sector performances
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart MAUNA-KEA-TECHNOLOGIESMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.1748EUR
Average target price
2.000EUR
Spread / Average Target
+1,044.16%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALMKT Stock
  4. Company Mauna Kea Technologies